Taysha Gene Therapies reported net income of -$46.64M for the quarter ended Jun 2026. This income statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 38.47M | 38.47M | 38.47M | 41.02M | 41.18M | 43.95M | 63.47M | 64.43M | 125.70M | 116.12M | 187.02M | 201.38M | 267.82M | 204.94M | 269.31M | 272.73M | 353.31M | 285.05M | 366.63M | 325.30M | |||||||
| Revenue & cost | |||||||||||||||||||||||||||
| Revenue | 4.71M | 2.40M | 4.75M | 3.60M | 3.41M | 1.11M | 1.79M | 2.02M | 2.30M | 1.99M | 5.49M | ||||||||||||||||
| Operating items | |||||||||||||||||||||||||||
| Research & DevelopmentR&D | 39.53M | 37.92M | 38.18M | 23.51M | 16.77M | 12.71M | 12.51M | 19.79M | 11.79M | 12.68M | 20.66M | 15.07M | 14.95M | 15.32M | 15.56M | 20.14M | 25.75M | 24.95M | 33.81M | 38.64M | |||||||
| Selling, General & AdministrativeSG&A | 11.15M | 11.81M | 11.47M | 9.87M | 8.68M | 7.34M | 8.75M | 5.99M | 8.59M | 6.72M | 7.08M | 7.34M | 7.90M | 6.63M | 8.16M | 8.60M | 8.28M | 8.83M | 9.68M | 12.15M | |||||||
| Other Operating ExpensesOther Opex | 36.42M | 0.62M | 0.45M | 4.84M | 3.43M | ||||||||||||||||||||||
| Operating ExpensesOpex | 50.68M | 49.72M | 49.65M | 33.37M | 25.46M | 56.47M | 21.27M | 25.78M | 21.00M | 19.85M | 27.74M | 22.41M | 27.69M | 21.95M | 23.72M | 28.74M | 34.02M | 33.78M | 43.49M | 47.35M | |||||||
| Operating IncomeOp. Inc | -50.68M | -49.72M | -49.65M | -33.37M | -25.46M | -53.97M | -16.56M | -23.38M | -16.25M | -16.25M | -24.33M | -21.30M | -25.90M | -19.93M | -21.42M | -26.75M | -34.02M | -28.30M | -43.49M | -47.35M | |||||||
| EBIT | -50.68M | -49.72M | -49.65M | -33.37M | -25.46M | -53.97M | -16.56M | -23.38M | -16.25M | -16.25M | -24.33M | -21.30M | -25.90M | -19.93M | -21.42M | -26.75M | -34.02M | -28.30M | -43.49M | -47.35M | |||||||
| Non-operating items | |||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.54M | 0.69M | 0.67M | 0.74M | 1.08M | 1.30M | 1.37M | 1.44M | 1.47M | 0.71M | 0.03M | 0.03M | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | |||||||
| Interest & Investment IncomeInt & Inv Inc | 0.04M | 0.03M | 0.01M | 0.03M | 0.01M | 0.20M | 0.32M | 0.22M | 1.11M | 1.92M | 1.69M | 1.44M | 2.11M | 1.70M | 1.33M | 1.86M | 3.17M | 2.87M | 2.59M | 2.33M | |||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.00M | -0.00M | -0.01M | -0.01M | 0.00M | 100.46M | -65.74M | 0.34M | -0.20M | -0.08M | -0.18M | -0.10M | 0.27M | 0.29M | 0.74M | -0.03M | -0.09M | ||||||||||
| Non Operating IncomeNon Op. Inc. | -0.51M | -0.66M | -0.67M | -0.72M | -1.07M | -1.11M | -1.06M | -1.21M | -100.84M | 63.99M | 0.27M | 0.37M | 0.37M | 1.15M | -0.11M | -0.13M | 1.29M | 0.45M | 1.08M | 0.71M | |||||||
| Net income details | |||||||||||||||||||||||||||
| EBT | -51.19M | -50.39M | -50.31M | -34.09M | -26.53M | -55.07M | -17.61M | -24.60M | -16.61M | -15.04M | -22.67M | -19.89M | -23.82M | -18.25M | -20.11M | -24.91M | -30.87M | -25.44M | -40.91M | -45.03M | |||||||
| Profit After TaxPAT | -51.19M | -50.39M | -50.32M | -34.09M | -26.53M | -55.08M | -17.62M | -24.60M | -117.09M | 47.74M | -24.06M | -20.93M | -25.52M | -18.79M | -21.53M | -26.88M | -32.73M | -27.85M | -42.41M | -46.64M | |||||||
| Income from Non-Controlling InterestsInc. Minority | 4.11M | -23.04M | |||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -51.19M | -50.39M | -50.31M | -34.09M | -26.53M | -55.07M | -17.61M | -24.60M | -16.61M | -15.04M | -22.67M | -19.89M | -23.82M | -18.25M | -20.11M | -24.91M | -30.87M | -25.44M | -40.91M | -45.03M | |||||||
| Consolidated Net IncomeConsol Net Inc. | -51.19M | -50.39M | -50.31M | -34.09M | -26.53M | -55.07M | -17.61M | -24.60M | -16.61M | -15.04M | -22.67M | -19.89M | -23.82M | -18.25M | -20.11M | -24.91M | -30.87M | -25.44M | -40.91M | -45.03M | |||||||
| Income towards Parent CompanyParent Net Inc | -51.19M | -50.39M | -50.31M | -34.09M | -26.53M | -55.07M | -17.61M | -24.60M | -16.61M | -15.04M | -22.67M | -19.89M | -23.82M | -18.25M | -20.11M | -24.91M | -30.87M | -25.44M | -40.91M | -45.03M | |||||||
| Net Income towards Common StockholdersNet Income | -51.19M | -50.39M | -50.32M | -34.09M | -26.53M | -55.08M | -17.62M | -24.60M | -117.09M | 47.74M | -24.06M | -20.93M | -25.52M | -18.79M | -21.53M | -26.88M | -32.73M | -27.85M | -42.41M | -46.64M | |||||||
| Additional items | |||||||||||||||||||||||||||
| EPS (Basic) | -1.35 | -1.34 | -1.32 | -0.85 | -0.65 | -1.25 | -0.28 | -0.38 | -0.93 | 0.41 | -0.10 | -0.09 | -0.10 | -0.08 | -0.08 | -0.09 | -0.09 | -0.09 | -0.12 | -0.13 | |||||||
| EPS (Diluted) | -1.35 | -1.34 | -1.32 | -0.85 | -0.65 | -1.25 | -0.28 | -0.38 | -0.93 | 0.41 | -0.10 | -0.09 | -0.10 | -0.08 | -0.08 | -0.09 | -0.09 | -0.09 | -0.12 | -0.13 | |||||||
| Shares Outstanding | 38.00M | 37.65M | 38.17M | 40.14M | 40.94M | 43.95M | 63.26M | 64.24M | 125.70M | 116.12M | 231.25M | 232.82M | 267.82M | 250.13M | 269.31M | 297.99M | 353.31M | 319.71M | 366.63M | 369.04M | |||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 38.00M | 37.65M | 38.17M | 40.14M | 40.94M | 43.95M | 63.26M | 64.24M | 125.70M | 116.12M | 231.25M | 232.82M | 267.82M | 250.13M | 269.31M | 297.99M | 353.31M | 319.71M | 366.63M | 369.04M | |||||||
| EBITDA | -50.68M | -49.72M | -49.65M | -33.37M | -25.46M | -53.97M | -16.56M | -23.38M | -16.25M | -16.25M | -24.33M | -21.30M | -25.90M | -19.93M | -21.42M | -26.75M | -34.02M | -28.30M | -43.49M | -47.35M | |||||||
| Interest ExpensesInt Expense | 0.54M | 0.69M | 0.67M | 0.74M | 1.08M | 1.30M | 1.37M | 1.44M | 1.47M | 0.71M | 0.03M | 0.03M | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M |